Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Boehringer Ingelheim International GmbH
Pharmaceutical Preparation ManufacturingGermany
Last verified 10 months agoboehringer-ingelheim.com
Boehringer Ingelheim International GmbH, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Ingelheim am Rhein, Germany. Founded in 1885, the company has established a strong global presence, with significant operations across Europe, North America, and Asia.
Specialising in prescription medicines, animal health, and biopharmaceutical contract manufacturing, Boehringer Ingelheim is renowned for its innovative therapies that address unmet medical needs. The company’s commitment to research and development has led to numerous breakthroughs in areas such as respiratory diseases, oncology, and diabetes management.
With a robust portfolio of unique products and a reputation for quality, Boehringer Ingelheim consistently ranks among the top pharmaceutical companies worldwide, reflecting its dedication to improving health and well-being across diverse populations.
25
DitchCarbon score
-17 vs industry average
Boehringer Ingelheim International GmbH’s score of 25 is lower than 38% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Boehringer Ingelheim International GmbH?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Boehringer Ingelheim International GmbH yet.
Boehringer Ingelheim International GmbH's reported carbon emissions
Boehringer Ingelheim International GmbH, a DE-based Pharmaceutical Preparation Manufacturing company, has not reported its direct (Scope 1), indirect from electricity (Scope 2), or value chain (Scope 3) carbon emissions data.
However, the organisation's climate commitments and initiatives are cascaded from its parent company, C.H. Boehringer Sohn AG & Co. KG. This includes data reported to CDP.
Assessing Boehringer Ingelheim International GmbH as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Boehringer Ingelheim International GmbH and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Boehringer Ingelheim International GmbH’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Boehringer Ingelheim International GmbH yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Inherited from C.H. Boehringer Sohn AG & Co. KGSign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Boehringer Ingelheim International GmbH10 months ago
25
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more